U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07460908) titled 'Comparison of Terlipressin Versus Octreotide in Patients With Hepatorenal Syndrome' on March 05.
Brief Summary: Hepatorenal syndrome is a serious complication of advanced liver disease in which kidney function rapidly worsens and can lead to life-threatening illness. Effective treatment is essential because delayed improvement in kidney function is associated with poor short-term outcomes. This randomized controlled trial will compare two commonly used medicines, terlipressin and octreotide, for the treatment of hepatorenal syndrome in adult patients admitted to Medical Unit III, Lahore General Hospital, Lahore. A total of 60 eligi...